Tag: Alkermes plc

Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1

– Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With Narcolepsy Type 1 – –...

Alkermes to Report Second Quarter Financial Results on July 29, 2025

DUBLIN, July 15, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m....

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsAlkermes plc

Embedded LLM Launches First-of-its-Kind Monetisation Platform for AMD AI GPUs

DualityBio’s Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

Bitget Expands Starlink-Powered PayFi Islands Initiative to Negros Oriental

Tag: Alkermes plc

Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1

Alkermes to Report Second Quarter Financial Results on July 29, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us